SCHEMBL23079599

SCHEMBL23079599

c1ccc2cc(-n3c4cc5ccccc5cc4c4cc5ccccc5cc43)ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 2/20 0.47
HTR3E A5X5Y0 1/20 0.47
HTR3B O95264 1/20 0.47
HTR5A P47898 1/20 0.47
HTR3D Q70Z44 1/20 0.47
HTR3C Q8WXA8 1/20 0.47
SIGMAR1 Q99720 1/20 0.47
HSP90AA1 P07900 1/20 0.46
MAPK10 P53779 8/20 0.42
MAPK9 P45984 7/20 0.42
MAPK8 P45983 2/20 0.42
CYP19A1 P11511 1/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
ALDH1A1 P00352 4/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
PMM2 O15305 1/20 0.41
MPI P34949 1/20 0.41
PHOSPHO1 Q8TCT1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13828934 0.93 KDM4E (0.48) HTR3AHTR3EHTR3BHTR5AHTR3D
SCHEMBL27453068 0.89 HTR3A (0.42) HTR3AHTR3EHTR3BHTR5AHTR3D
SCHEMBL15073877 0.87 KDM4E (0.56) HTR3AHTR3EHTR3BHTR5AHTR3D
SCHEMBL15073728 0.87 KDM4E (0.56) HTR3AHTR3EHTR3BHTR5AHTR3D
SCHEMBL24766132 0.87 HTR3A (0.38) HTR3AHTR3EHTR3BHTR5AHTR3D
SCHEMBL6938289 0.86 KDM4E (0.50) HTR3AHTR3EHTR3BHTR5AHTR3D
SCHEMBL17989824 0.85 KDM4E (0.55) HTR3AHTR3EHTR3BHTR5AHTR3D
SCHEMBL21369850 0.85 KDM4E (0.48) HTR3AHTR3EHTR3BHTR5AHTR3D
SCHEMBL19769526 0.85 KDM4E (0.53) HTR3AHTR3EHTR3BHTR5AHTR3D
SCHEMBL22302486 0.84 MAPK10 (0.36) HTR3AHTR3EHTR3BHTR5AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210070717-A1 ORGANIC COMPOUND BASED ON TRIAZINE AND BENZOXAZOLE AND APPLICATION THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) 2021-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210070717-A1 ORGANIC COMPOUND BASED ON TRIAZINE AND BENZOXAZOLE AND APPLICATION THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, EED, OCIAD2 HTR3A 1209/4885HTR3E 825/4885HTR3B 960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.